Engineered immune cells take aim at childhood cancer in new trial
Disease control
Recruiting now
This study tests a new treatment called hALK.CAR T cells for children and young adults with high-risk neuroblastoma that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to better recognize and atta…
Phase: PHASE1, PHASE2 • Sponsor: Roberto Chiarle • Aim: Disease control
Last updated May 26, 2026 06:06 UTC